Alternatives to Veradigm Real-World Evidence

Veradigm Payerpath offers a comprehensive suite of revenue cycle management solutions designed to enhance financial performance for healthcare organizations by improving communications with both payers and patients, ultimately increasing practice profitability across various specialties and sizes. By addressing issues such as incomplete information, incorrect coding, and data entry mistakes, the system ensures that claims are submitted cleanly and accurately. It also guarantees that claims are correctly coded, devoid of missing details, and free from errors before submission. With advanced analytical reporting, practices can benchmark their performance against state, national, and specialty peers, enabling them to optimize productivity and boost financial outcomes. Additionally, Veradigm Payerpath helps remind patients about their appointments while confirming their insurance coverage and benefits, streamlining the process. The platform further automates the billing and collection of patient responsibilities, making it easier for practices to manage finances. Notably, Veradigm Payerpath's integrated solutions are agnostic to practice management systems, ensuring seamless compatibility with all major PM platforms, which enhances its versatility in various healthcare settings. This flexibility allows practices to focus more on patient care while efficiently managing their financial operations.

Veradigm ePrescribe offers a thorough and user-friendly electronic prescribing solution, ensuring that both you and your patients are supported throughout the entire process. Whether you seek a budget-friendly e-prescribing option to save time and eliminate the need for a paper script pad, or you desire advanced features that keep you compliant with current regulations, Veradigm ePrescribe stands out as the reliable choice, utilized by more than 140,000 prescribers and handling hundreds of millions of transactions annually. By integrating electronic prescribing into your clinical workflow, you can streamline your practice, leading to improved medication adherence, enhanced patient satisfaction, and increased operational efficiency. You can e-prescribe from any location with internet access, including on your mobile device, making it a convenient option for busy healthcare professionals. In addition to simplifying the prescribing process and reducing unnecessary calls and faxes, Veradigm ePrescribe also provides access to patients’ medication histories and formularies, along with automatic interaction checks to enhance safety and efficiency in prescribing. Its advanced e-prescribing features not only support compliance but also foster a more connected and informed healthcare experience for both providers and patients alike.

Verana Health operates as a platform for real-world data that converts both structured and unstructured information from electronic health records into curated, de-identified, disease-focused data modules through its clinician-informed and AI-enhanced VeraQ population health data engine. By aggregating data from key collaborations with prominent medical registries, including the American Academies of Ophthalmology, Neurology, and Urological Association, the platform integrates insights from over 20,000 clinicians and approximately 90 million patient records, thereby supplying high-quality datasets in near real-time for the purposes of generating real-world evidence, identifying clinical trial sites and subjects, reporting clinician quality, and managing medical registries. Users can access this wealth of information through cloud services like AWS Data Exchange and Amazon Redshift, which provide self-service API access, a user-friendly dashboard, and tools for customizable cohort discovery. Furthermore, the system employs advanced AI and machine learning algorithms along with comprehensive data quality assessments to ensure the reliability and accuracy of the information provided. This innovative approach not only facilitates efficient data utilization but also enhances the overall quality of healthcare research and practice.

The healthcare sector has undergone remarkable transformations in recent years and continues to advance rapidly. To mitigate the challenges posed by supply chain interruptions, clinician and staff fatigue, and financial strains, Veradigm's Enterprise Resource Planning (ERP) system plays a crucial role. By providing integrated solutions, Veradigm ERP significantly improves an organization's capability to manage its supply chain and financial operations through a unified platform, allowing managers to gain deeper insights and better control over their performance. This comprehensive approach not only aids in managing expenses and capital but also supports the broader financial well-being of the organization. Additionally, Veradigm Fiscal Management offers a user-friendly solution for accounts payable, general ledger, project management, and fixed assets, which helps streamline operations, reduce paper usage, analyze critical data, and uncover significant cost efficiencies across the enterprise. Furthermore, it features same-day electronic payments to enhance the efficiency of the payment process, ensuring timely financial transactions. Through these innovative tools, organizations can position themselves for sustainable growth and improved operational effectiveness.

FollowMyHealth® is an innovative, mobile-centric patient engagement platform designed for healthcare providers, hospitals, and health systems that aim to enhance the health of their patient populations and improve care quality. Catering to both outpatient and inpatient settings, FollowMyHealth offers a customizable engagement solution that empowers organizations to navigate the changing landscape of healthcare by transforming the way clinicians connect with their patients. We believe the key to effective engagement in both ambulatory and hospital settings lies in fostering an environment where patients can take an active role in their own care using the devices they are familiar with. With Veradigm technology, we facilitate timely and meaningful conversations, ensuring that patients are not just passive recipients but integral participants in their healthcare journey. Our clients are equipped with comprehensive tools that provide personalized content throughout every step of the care continuum, delivered precisely when it's needed, thereby enhancing the overall patient experience. By prioritizing patient involvement, we aim to create a more collaborative healthcare environment that benefits everyone involved.

Flatiron Health's Evidence Solutions provide a versatile method for generating real-world evidence, both prospective and retrospective, which aids life sciences companies in efficiently meeting their oncology research objectives. At the heart of these offerings is Flatiron Horizon, a comprehensive platform that combines a rich database of more than 5 million anonymized patient records and 1.5 billion data points, coupled with advanced curation techniques and disease-specific machine learning models. This innovative platform is designed to facilitate various phases of the biopharma lifecycle, including discovery, clinical study design, regulatory submissions, and post-marketing commitments. Furthermore, Flatiron's services deliver customized real-world data configurations that cater specifically to oncology, enabling prospective evidence generation through minimally invasive studies and optimizing protocols for better patient identification. Additionally, the platform ensures a streamlined transfer of data from electronic health records to electronic data capture systems with the functionality of Flatiron Clinical Pipe, enhancing overall research efficiency and effectiveness. Such capabilities position Flatiron Health as a leader in transforming oncology research through the power of real-world data.

Veradigm AccelRx offers a complimentary, automated, all-encompassing solution designed to optimize the fulfillment of specialty medications for your patients. By reducing the time it takes to initiate therapy, this system can improve medication adherence and patient outcomes, while also minimizing the administrative burden of phone calls and faxes on your team. AccelRx integrates electronic enrollment, consent, prior authorization, and prescriptions into one seamless platform, enabling your practice to greatly decrease the fulfillment time for specialty drugs across all payers. With just a click, patient information is automatically filled in on enrollment forms and other necessary documents. This user-friendly platform serves as a transformative tool for managing specialty medications effectively. Furthermore, it enhances your ability to oversee a wide range of specialty drugs, including features for electronic prior authorization (ePA), all within your current electronic health record (EHR) system. This comprehensive approach not only streamlines processes but also supports better patient care and operational efficiency.

Ambulatory practices encounter a myriad of challenges in today's healthcare landscape. Balancing the demands of optimizing appointment schedules with the need to simplify documentation and diagnostic processes can often complicate communication with fellow physicians, insurance providers, and pharmacies, all while adhering to evolving regulatory requirements. Veradigm Professional EHR™, a system originally developed by physicians, stands out as the leading choice for medical practices aiming to enhance patient safety, operational efficiency, and financial performance. This innovative EHR features user-friendly, one-click templates that allow physicians to effectively document patient encounters based on historical data, enabling swift modifications with minimal effort—ultimately boosting provider satisfaction. Additionally, the Physician Desktop feature offers a streamlined approach for healthcare providers to oversee their patient populations, consolidating comprehensive clinical information into a single, accessible screen for better decision-making and care coordination. This integration significantly enhances the overall workflow within practices, making it easier for providers to deliver high-quality care.

The Aetion Evidence Platform® provides essential real-world evidence tailored for life sciences companies, payers, and risk-bearing providers. Our mission is to tackle significant healthcare inquiries: identifying the most effective treatments, determining their ideal patient populations, and establishing the optimal timing for their application. This approach directly translates into improved decision-making. Serving as a collaborator to many of the leading 20 global biopharma companies, prominent payers, and the FDA, Aetion plays a pivotal role in shaping the most vital decisions within the industry. Our transparent analytical methods facilitate advancements in product development, commercialization strategies, and payment innovations, steering healthcare into a new age. By transitioning the use of real-world evidence from merely descriptive analytics to deriving causal insights, the Aetion Evidence Platform is at the forefront of this evolution. Furthermore, we provide timely answers within a matter of days or weeks, delivering the swift results necessary to enhance both clinical and financial outcomes. Make the most of your available data by transforming it into actionable insights that can be utilized immediately for better healthcare solutions.

Genoox is revolutionizing the field of genomics through its dynamic and expanding community, which enables the accumulation of the most pertinent database and facilitates the delivery of actionable, real-world genomic insights that significantly affect lives, enhance clinical outcomes, and influence healthcare business practices. By harnessing community power, Genoox merges public data with community-generated information to optimize the journey from DNA sample to clinical report, thereby improving patient care through the accessibility and applicability of genomic data at critical moments. The company's innovative solutions are transforming the landscape of genomics, while also supporting research and life sciences enterprises with an insightful platform that leverages real-world data and evidence, bolstered by comprehensive genomic analytics, which assists researchers in simplifying intricate genomic information and achieving meaningful breakthroughs with cutting-edge genetic tools. Moreover, Genoox collaborates with biosystems firms like DNA sequencing companies to integrate its advanced genomic engine with specialized assays, further enhancing the capabilities of the entire genomics ecosystem. Ultimately, Genoox stands at the forefront of genomic innovation, consistently aiming to empower healthcare professionals and researchers alike.

The advanced features of the Inovalon ONE® Platform enable our clients and collaborators to thrive by utilizing extensive industry connections, vast primary-source real-world data, advanced analytics, and robust cloud-based technologies to enhance healthcare outcomes and economics. Central to modern healthcare is the necessity to consolidate and scrutinize vast amounts of varied data, extract valuable insights from these analyses, and apply this knowledge to effect significant improvements in patient outcomes, operational performance, and healthcare economics. With analytics and capabilities employed by over 20,000 clients, we draw upon the primary source data from more than 69.5 billion medical events, encompassing one million healthcare professionals, 611,000 clinical environments, and 350 million distinct patients. This extensive network of data and analytics is crucial for driving innovation and efficiency in the healthcare sector, fostering an environment where informed decisions lead to substantial advancements.

ConcertAI stands out as a prominent provider of AI-driven solutions within the healthcare sector, particularly in the field of oncology. Their core mission revolves around enhancing patient outcomes and expediting insights by leveraging top-tier real-world data, cutting-edge AI technologies, and deep scientific knowledge. The company presents an array of products and services aimed at improving both clinical research and patient care experiences. Their Real-World Data Products deliver extensive, customized datasets that cater to diverse research needs across various enterprises. By simplifying clinical trial processes, their digital trial solution ensures efficiency, while the Clinical Trial Optimization (CTO) platform employs extensive AI capabilities to refine the design and implementation of trials specifically in oncology and hematology. Additionally, in partnership with NeoGenomics, ConcertAI has introduced CTO-H, a software-as-a-service (SaaS) solution that concentrates on hematological malignancies, providing sophisticated research analytics and optimizing operational workflows. This integration of advanced technologies not only enhances research capabilities but also significantly contributes to the advancement of patient care in complex medical fields.

Panalgo’s Instant Health Data platform is an all-encompassing software suite for healthcare analytics designed to simplify programming complexities and expedite the analysis of real-world data across various sectors, including life sciences, pharmaceuticals, payers, providers, government, and academia. This platform assimilates a wide range of health data sources—such as claims, electronic health records, registry information, and other real-world datasets—and transforms them into a cohesive, analysis-ready format using a healthcare-specific data model alongside a rich library of algorithms. This enables fast, scalable, and clear analytics without the conventional barriers of coding. Users can benefit from point-and-click analytics, personalized dashboards, statistical assessments, machine learning predictions, automated documentation, and collaborative reporting, empowering stakeholders to efficiently investigate, interpret, and disseminate insights. Additionally, integrated features like Ella AI offer natural-language, generative-AI support that assists in cohort building, insight generation, and decision-making processes, further enhancing the platform's utility for its users. As a result, Panalgo’s IHD not only streamlines analytics but also fosters a collaborative environment for various healthcare stakeholders.

MMIT (Managed Markets Insight & Technology) provides a robust analytics and healthcare market access platform that consolidates critical data regarding coverage, policy, restrictions, payers, and real-world insights, enabling life sciences and healthcare organizations to navigate the complexities of therapy coverage, reimbursement, and accessibility within the U.S. healthcare landscape. The MMIT Platform acts as a comprehensive resource where users can delve into a variety of integrated solutions, such as formulary intelligence, medical policy insights, payer landscape and enrollment information, tools for coverage searches, API connectivity, and analytics tailored to support commercialization efforts, competitive assessments, and strategies for patient access. Additionally, it offers in-depth analysis of drug coverage statuses, restrictions, payer dynamics, and market segmentation, featuring tools designed to assess patient access hurdles, guide field engagement initiatives, anticipate policy changes, and seamlessly incorporate coverage information. Ultimately, MMIT empowers its users to make informed decisions that enhance their strategic objectives in the healthcare sector.

Truveta operates as a health data and analytics platform focused on leveraging information to enhance patient lives. By consolidating de-identified electronic health records from more than 30 healthcare systems, it provides researchers with access to a rich array of patient data, which includes clinical notes, imaging, and genomic information. This vast repository represents data from upwards of 120 million patients, giving a well-rounded perspective on healthcare delivery throughout the United States. The Truveta Studio, which serves as the platform's analytics hub, equips researchers with sophisticated tools like notebooks and dashboards, all maintained within a secure and HIPAA-compliant framework. With daily updates to its data, the platform guarantees that insights into patient care and outcomes are both current and relevant. Furthermore, Truveta's dedication to data integrity is showcased by its implementation of the Truveta Language Model, an advanced AI framework that efficiently translates EHR data into precise and reliable data points for the advancement of medical research. This commitment not only enhances research capabilities but also fosters a deeper understanding of healthcare trends and patient needs, ultimately contributing to improved health outcomes.

Atropos Health delivers immediate access to evidence derived from real-world data, effectively bridging the gaps in the healthcare and life sciences sectors. This innovative approach has been shown to enhance clinical outcomes, speed up research initiatives, and improve operational efficiency. By swiftly converting medical data into actionable real-world evidence, Atropos Health reduces the time needed for research from months to mere minutes. Central to its offerings is a generative evidence acceleration operating system that can securely incorporate and structure medical data for future applications. With robust analytics tools, users can generate evidence on demand, utilizing either their own data following a quick setup or tapping into our extensive global evidence network, which includes over 160 million patient records and a library of 10,000 prior studies. Partnering with Atropos Health allows leading health systems and life science organizations to fast-track research, refine clinical trials, enhance clinical decision-making, manage care variation effectively, and much more. Together, we are reshaping the future of healthcare through data-driven insights and collaborative innovation.

Enhance your digital transformation journey while uncovering valuable insights from your data with customized health analytic solutions. Featuring an intuitive drag-and-drop interface, SAS Health Cohort Builder allows users to query and create cohorts based on temporal relationships without any coding skills necessary. This user-friendly tool enables easy exploration of cohort traits and the impact of various inclusion or exclusion criteria on patient groups, assisting in assessing the feasibility of studies. You have the capability to save cohort definitions for future use, modify them as needed, and apply them across different real-world data resources for comparative analysis, ultimately conserving both time and resources. Additionally, you can validate findings and conduct further analyses through in-memory processing and visualization in SAS or other platforms such as R, Python, and various third-party visualization applications. On the other hand, SAS Health: Episode Builder empowers you with the ability to view and modify episode definitions directly, ensuring that you have control over the process. With SAS’s fully documented logic to generate episodes of care, you can rest assured that the underlying business rules are both transparent and subject to audit at any time, further enhancing the reliability of your health data analytics. This combination of features positions SAS as a leading tool in the realm of health analytics.

Combine and liberate your disorganized health information through an interactive AI and NLP solution that provides valuable health insights for various stakeholders. This innovative technology serves Providers by hastening the data abstraction process and ensuring the clinical information validation found within notes, thus minimizing the time and costs associated with identifying care gaps, assessing the quality of care through dashboards, and producing registry reports. For Payers, it facilitates the integration and analysis of claims alongside clinical notes, enhancing the management of high-risk and high-cost member populations. In the realm of Life Sciences, this solution enables swift patient matching to clinical trials using databases alongside clinical note data, maximizing the potential of real-world clinical evidence. Ember offers a comprehensive approach that merges NLP with predictive analytics, streamlining healthcare analytics for unstructured data to boost quality, efficiency, and outcomes in the healthcare system. As a result, stakeholders can make informed decisions that lead to improved patient care and resource allocation.

Cytel stands out as a prominent global innovator in software for clinical trial design, biometrics, and advanced analytics, focusing on maximizing the efficiency of clinical trials while aiding pharmaceutical companies in harnessing the full scope of both clinical and real-world data. Established in 1987 by renowned statisticians Cyrus Mehta and Nitin Patel, Cytel has consistently been a leader in adaptive clinical trial technology and the field of biostatistics. Its software solutions, notably the East Horizon platform, facilitate accurate trial design and simulation, employing adaptive and Bayesian methodologies to enhance protocols and expedite the drug development process. The East Horizon platform serves as a comprehensive integration of Cytel's reliable software offerings, featuring R integration that significantly improves trial design functions. Furthermore, Cytel provides the Xact software suite, which is an all-encompassing toolkit designed for statistical analysis of small datasets, including those with sparse and missing data. By continuously innovating and expanding its product offerings, Cytel remains committed to providing cutting-edge solutions that meet the evolving needs of clinical research.

TriNetX operates as a worldwide health research network that links healthcare institutions with life sciences firms to enhance real-world research and expedite the creation of innovative therapies. Utilizing a self-service platform that adheres to HIPAA, GDPR, and LGPD regulations, TriNetX allows users to tap into federated electronic health records, various datasets, and consulting collaborations. This capability empowers the global research community to enhance protocol design, optimize trial operations, improve safety signal assessments, and amplify the generation of real-world evidence. The network boasts a comprehensive dataset representing over 275 million patients from 150 healthcare organizations across 25 nations, thereby offering a rich resource for research endeavors. Researchers have taken advantage of the TriNetX network to examine upwards of 26,000 protocols and present more than 7,000 clinical trial opportunities to the healthcare members, thereby cutting site identification time for clinical trials by an impressive 50%. In doing so, TriNetX not only fosters collaboration among entities but also catalyzes advancements in medical research and patient care worldwide.

At ArborMetrix, our aim is to enhance healthcare through data science, while our enthusiasm lies in providing impactful, user-friendly technology and analytics. Our advanced healthcare analytics solutions are designed to yield precise, clinically-rich insights that enhance clinical outcomes, boost financial effectiveness, add value for stakeholders, and evaluate the real-world success of treatments, procedures, medical devices, and pharmaceuticals. One of the significant benefits of patient registries is their application across various medical fields, with post-market surveillance standing out as a particularly important function. To assist you in establishing a reliable data resource, we follow a systematic approach. First, it’s essential to have an effective and secure method for gathering substantial amounts of real-world data, which is crucial for thorough analysis. By utilizing the appropriate technology, you can aggregate data from diverse sources such as medical records, regulatory bodies, and patient-reported outcomes to support post-market surveillance initiatives. This comprehensive approach not only streamlines the data collection process but also enhances the overall quality of insights derived from the analysis.

PicnicHealth serves as a bridge between patients and researchers, providing comprehensive and purpose-driven real-world data. By engaging with patients who willingly share their medical information for research purposes, we can create an extensive understanding of patient health that encompasses all their healthcare providers, rather than being limited to a single site or specialist. Our established patient communities and efficient recruitment methods through various direct-to-patient channels make it simple to assemble the right cohort of patients. In just ten minutes, patients can register and give consent, gaining access to their own medical records. If you currently have patients involved in ongoing registries or clinical trials, consider directing them to PicnicHealth for streamlined setup. Our research platform is designed to offer tailored real-world data at the individual patient level, allowing for precise specifications regarding the data elements to be extracted from medical records, such as doctors' notes and narrative text. This innovative, patient-focused approach not only enhances the data we gather but also encourages patients to play an active role in the research process. Ultimately, we believe that empowering patients in this way fosters a deeper understanding of health outcomes and improves the overall quality of research.

Nygen serves as a cloud-driven platform for the analysis and discovery of single-cell RNA sequencing (scRNA-seq) and multi-omics data, allowing researchers to seamlessly upload, explore, visualize, analyze, and interpret intricate cellular datasets through an easy-to-use, no-code interface that promotes drag-and-drop workflows and sophisticated scientific analysis without the need for programming knowledge. This platform merges Nygen Analytics for swift and reproducible exploration of scRNA-seq data with collaborative dashboards that produce publication-ready outputs, integrates Nygen Database for easy access to curated single-cell datasets to enhance research and comparative studies, and includes Nygen Insights, an AI-enhanced feature that offers precise cell annotations, thorough disease impact assessments, and customized biological insights. Furthermore, it accommodates a variety of data formats, integrates public datasets, fosters secure cloud collaboration, and offers functionalities such as literature-linked evidence and analyses focused on biomarkers, ultimately empowering researchers to derive meaningful conclusions from their data. By streamlining complex analytical processes, Nygen significantly enhances the efficiency of scientific research and discovery.

REDCap Cloud serves as a comprehensive data-science platform that empowers organizations to gather, integrate, standardize, analyze, and disseminate clinical and research data that meets real-world and regulatory standards, all within a cohesive, standards-driven system. This platform facilitates the complete lifecycle of randomized clinical trials and real-world evidence research by providing diverse modules tailored for intricate trial design and execution, a centralized clinical data hub that integrates both eCRF and non-eCRF sources, AI/ML capabilities for real-time operational and data insights, and seamless connectivity to eSource and EHR systems. Additionally, it enhances patient engagement through tools like ePRO/eCOA and wearable devices, accommodating both hybrid and decentralized trial models. The analytics features include options for synthetic control arms and digital twins, ensuring adherence to global security compliance standards. Ultimately, REDCap Cloud is designed to mitigate data silos, eliminate vendor fragmentation, facilitate bidirectional data flows, and offer sponsors, CROs, and health systems comprehensive visibility and oversight regarding site performance, study data integrity, and regulatory preparedness. By streamlining these processes, organizations can achieve greater efficiency and effectiveness in their research endeavors.

The MDClone ADAMS Platform serves as a robust, self-service environment for data analytics that facilitates collaboration, research, and innovation within the healthcare sector. With this groundbreaking platform, users gain real-time, dynamic, secure, and independent access to valuable insights, effectively dismantling obstacles to healthcare data exploration. This empowers organizations to embark on a journey of continuous learning that enhances patient care, optimizes operations, encourages research initiatives, and fosters innovation, thereby driving actionable outcomes throughout the entire healthcare ecosystem. Additionally, the use of synthetic data allows for seamless collaboration among teams, organizations, and external partners, enabling them to delve into the essential information they require precisely when it is needed. By tapping into real-world data sourced directly from within health systems, life science organizations can pinpoint promising patient cohorts for detailed post-marketing analysis. Ultimately, this innovative approach transforms the way healthcare data is accessed and utilized for life sciences, paving the way for unprecedented advancements in the field. As a result, stakeholders can make informed decisions that significantly impact patient outcomes and overall healthcare quality.

The expenses, intricacies, and lengthy timelines tied to traditional methods of evidence generation hinder the agile nature of research and the broader incorporation of genuine patient insights within treatment development and commercial processes. Our HyperStream serves as the largest real-time stream of patient experience data globally, documenting the genuine digital narratives of diseases as expressed by real patients on various online platforms. Pharos acts as a web-based tool for evidence generation and a research framework that leverages its combined data streaming and AI functionalities to effectively gather online patient experience data, allowing teams to swiftly uncover vital evidence when necessary. Thus far, the Pharos Suite has proven effective in generating valuable evidence and patient insights across a variety of therapeutic areas and medical conditions, demonstrating its versatility and impact on research practices. This innovative approach not only enhances the speed of evidence gathering but also enriches the understanding of patient experiences in real-time.

At Genospace, we recognize that the evolution of precision medicine is being propelled by advancements in genomics, yet the challenge of effectively scaling its implementation remains unresolved. Our mission is to bridge this gap. Our innovative platform aims to transform biomedical data into valuable insights that are easily accessible for all, particularly for those actively involved in delivering care. Equip your clinicians and researchers with essential information that empowers them to make well-informed choices while participating in our goal of utilizing intricate molecular data to enhance patient outcomes and speed up the processes of drug development and research. In this context, the significance of large-scale population data for drug discovery and research cannot be overstated. Utilize cohort-driven analyses through the Genospace platform to support your research initiatives. We have a strong focus on clinical trial research, enabling the Genospace platform to seamlessly align fragmented patient information with intricate trial requirements, thus facilitating quicker patient recruitment. Furthermore, our platform is designed to integrate genomic medicine into standard clinical care practices, making it easier than ever to harness the power of genomics in everyday healthcare. Together, we can push the boundaries of what’s possible in patient care and research.

Offering a robust, cloud-centric platform, comprehensive longitudinal electronic health record (EHR) data, and advanced analytical tools, this system assists healthcare providers and life sciences organizations in discovering new relationships among previously isolated healthcare information. It comprises a suite of software-as-a-service (SaaS) applications that facilitate swift population management, performance evaluation, and meaningful engagement with both patients and providers. This solution allows healthcare organizations to gather, link, and merge information from numerous varied sources across their entire enterprise and clinically integrated networks. It empowers designers of care and quality programs to effectively search and explore populations related to diagnoses, treatments, outcomes, costs, and demographics. Furthermore, it swiftly pinpoints target populations, enabling improved decision-making regarding risk-stratified care management. Additionally, it presents an integrated framework that correlates vast amounts of clinical, operational, and financial events into benchmarks and scorecards for insightful comparisons, ultimately enhancing the overall quality of care delivered. This comprehensive approach not only streamlines data integration but also supports innovative healthcare solutions.

The Digital Health Indicator (DHI) serves as a benchmark for evaluating the advancement of a comprehensive digital health ecosystem. This ecosystem connects healthcare providers and teams with individuals, allowing them to effectively manage their health and wellness through secure and private digital tools, accessible at any time and place care is required. The operational and care delivery practices are focused on achieving outcomes, driven by data and real-world evidence, to ensure exceptional quality, safety, and sustainable performance. Grounded in the principles and evidence outlined in the HIMSS Digital Health Framework, the DHI assesses four key areas that facilitate your organization's journey toward digital health transformation. Establish governance that fosters a sustainable workforce by utilizing outcomes data, ensuring that information flows seamlessly in real-time across the healthcare system. Additionally, it emphasizes the importance of proactively addressing population health outcomes, leveraging comprehensive analytics for informed decision-making, while also maintaining real-time tracking capabilities to enhance overall care delivery. This multifaceted approach not only supports the present needs but also lays a foundation for future advancements in digital health.

Clinithink stands out as a premier technology firm in the healthcare sector, focusing on artificial intelligence solutions that convert unstructured medical information into valuable insights. The company's proprietary CLiX platform leverages Clinical Natural Language Processing (CNLP) to decipher intricate clinical narratives, which empowers healthcare providers to improve both patient outcomes and operational productivity. Clinithink delivers customized solutions across various domains, including life sciences, revenue cycle management, and population health, effectively tackling issues such as identifying patient cohorts, maximizing reimbursement, and monitoring disease progression. With its cutting-edge technology, Clinithink has earned the confidence of top pharmaceutical and healthcare entities globally, establishing its leadership in the realm of healthcare AI and digital health progress. Moreover, the CLiX platform is adept at comprehending a wide array of unique and intricate clinical concepts, including but not limited to certainty, severity, laterality, and temporality, further enhancing its utility in clinical settings. As the demand for innovative healthcare solutions grows, Clinithink remains committed to advancing its technology to meet the evolving needs of the industry.

By leveraging visual analytics through TIBCO Spotfire®, PerkinElmer Signals Translational offers a comprehensive suite of tools designed to harmonize, manage, search, aggregate, and analyze extensive datasets consistently for translational research, all while ensuring scalability. This platform, driven by TIBCO Spotfire®, supports precision medicine initiatives by providing an unparalleled solution for biomarker discovery and patient stratification. The Linear Mixed Effect App (LME) within Signals Translational empowers researchers to evaluate the influence of various factors on specific phenotypes, allowing for adjustments related to random variables during analysis. Furthermore, it enables the identification of genes significantly affecting cancer stage progression, irrespective of patient origins. Notably, the LME models excel at addressing issues such as missing values and outliers, making them a robust choice for discovering potential biomarkers. Consequently, the integration of these advanced analytics tools enhances the efficacy of translational research in identifying key biomarkers that can lead to more personalized treatment approaches.

Watson Health leverages its foundational strengths, extensive expertise in the healthcare sector, and cutting-edge technological offerings—such as AI, blockchain, and data analytics—to empower clients in their digital transformation journeys. By integrating innovative technology with seasoned consulting services, we assist organizations in becoming more efficient and resilient, ultimately enhancing their ability to fulfill their commitments to the communities they serve. Explore the Watson Health solutions designed to optimize clinical, financial, and operational effectiveness while also applying analytics to improve initiatives aimed at vulnerable populations. Additionally, our offerings enhance clinical trials and facilitate the generation of real-world evidence, which is crucial for advancing healthcare practices. We also provide solutions that enable payers to effectively manage performance, member engagement, and business networks. Furthermore, Watson Health assists organizations with benefits analytics and ensuring business continuity, making us a comprehensive partner in the healthcare landscape. This multifaceted approach highlights our commitment to driving positive outcomes across various facets of health systems and enhancing overall service delivery.

Sorcero is an innovative platform powered by artificial intelligence that aims to convert intricate medical data into practical insights for the life sciences sector. It offers a range of products such as Medical Insights Management, Intelligent Publication Monitoring, Plain Language Summaries, and Intelligent Systematic Literature Review, all of which work together to unify and interpret both structured and unstructured data from diverse sources. By leveraging AI to dissect medical themes, notes, and research findings, Sorcero provides clear and high-quality responses to challenging medical inquiries, thereby assisting teams in Medical Affairs, Pharmacovigilance, and Regulatory Affairs in making better-informed choices. The platform enhances rapid literature monitoring, facilitates content creation, and supports evidence-based decision-making, significantly improving patient outcomes while also streamlining operational processes. Additionally, Sorcero's capabilities can lead to a more effective collaboration among various stakeholders within the healthcare ecosystem.

Harnessing the world's largest real-time data stream on patient experiences, coupled with advanced Artificial Intelligence for analysis and a robust analytics platform that distills patient feedback into clear insights, empowers stakeholders to uncover unmet needs and gain comprehensive insights into the challenges of disease and treatment, ultimately facilitating the design and implementation of more tailored therapies while consistently prioritizing patient care. It can be disheartening to realize that, given existing resource limitations and methodological constraints, achieving optimal patient outcomes can often feel unattainable. By selecting specific diseases, age groups, geographical locations, and any necessary inclusion or exclusion criteria for your research, you can streamline the process of gathering real-world data on a global scale, thereby accessing a vast array of patient populations much more efficiently and without unnecessary complications. This approach not only accelerates research but also enhances the overall understanding of patient experiences in diverse contexts.

Our comprehensive primary source dataset stands out as the most extensive and varied resource available for researchers and analysts in the healthcare sector, enabling them to gain profound insights aimed at enhancing both health outcomes and economic efficiency. Propel the future of healthcare by utilizing pertinent data extracts that encompass a wide spectrum of care, featuring detailed provider identification, a comprehensive view of the patient journey, and the capability to securely connect with external data sources. Boost research efforts and elevate healthcare outcomes with longitudinally linkable, deidentified real-world data that is crucial for informed decision-making. We conduct over 1,100 rigorous data integrity checks to guarantee both consistency and precision, employing industry-standard methodologies for quality assurance and seamless integration. Uncover innovative insights through rich and pertinent real-world data. Additionally, harness custom extracts from both open and proprietary primary sources to expedite research processes and enhance clinical outcomes alongside provider performance. Our commitment to data quality and relevance ensures that healthcare professionals can make the best decisions possible.

Efficiently merge the multiomic information of patients with their health records to provide more tailored care solutions. Implement specialized data repositories to facilitate extensive analyses and foster collaborative research initiatives on a population-wide scale. Expedite research processes by leveraging adaptable workflows and comprehensive computational tools. Ensure the safeguarding of patient privacy through adherence to HIPAA standards, complete with robust data access and logging mechanisms. AWS HealthOmics empowers healthcare and life science organizations, along with their software collaborators, to securely store, retrieve, and analyze diverse omics data, such as genomic and transcriptomic information, ultimately yielding valuable insights that enhance health outcomes and propel scientific advancements. Manage and evaluate omics data for extensive patient cohorts to discern how variations in omics relate to phenotypic expressions within the population. Develop consistent and accountable clinical multiomics workflows designed to minimize turnaround times while boosting efficiency. Seamlessly incorporate multiomic assessments into clinical trials aimed at evaluating new therapeutic candidates, thereby enhancing the overall drug development process. By harnessing these innovative approaches, organizations can ensure a deeper understanding of patient health and contribute to groundbreaking research findings.

Understand your assets, their locations, their functions, and any potential hazards they may present. Neara is a cutting-edge platform that creates three-dimensional interactive representations of essential infrastructure systems and resources, enabling users to simulate real-life situations, evaluate both present and future risks, and effectively manage maintenance and emergency planning. Given the challenges posed by deteriorating infrastructure, the shift towards electrification, extreme weather conditions, climate change effects, microgrid integration, fluctuating energy demands, and overall load increases, it is crucial to have advanced utility and design software that can transform the grid for future needs. As power grids evolve to accommodate a greater share of renewable energy, our solutions can help expedite this transition. Neara focuses on risk assessment and mitigation at both the asset and network levels, delivering intelligent analytics that enhance safety, boost operational efficiency, and contribute to the establishment of a more sustainable energy grid. This comprehensive approach not only strengthens infrastructure resilience but also supports a greener future for energy distribution.

Plexus is an innovative platform that utilizes AI to analyze healthcare data, aiming to enhance the targeting of healthcare providers and map clinical networks effectively. By harnessing insights from over a billion data points, the software skillfully identifies and profiles key clinicians in various therapeutic fields. It bolsters engagement efforts through precision segmentation driven by predictive analytics, enabling pharmaceutical companies to focus on healthcare professionals who significantly influence patient care and the adoption of treatments. The platform also creates detailed clinical network maps at various scales—local, regional, and national—offering a thorough understanding of the relationships between healthcare professionals that aids in the development of personalized marketing, sales, and medical approaches. In addition to this, Plexus integrates a variety of data sources, such as claims data and future prescription estimates, to enhance targeting efforts and optimize resource distribution. By providing valuable insights for marketing, sales, medical teams, and business intelligence divisions, Plexus ultimately empowers organizations to make informed decisions that can drive better patient outcomes. This comprehensive approach ensures that stakeholders have the necessary tools to navigate the complexities of the healthcare landscape effectively.

Lightning Rod is an innovative AI platform that streamlines the process of converting chaotic, unstructured real-world information into polished, production-ready datasets and specialized AI models without the need for manual labeling. This platform allows users to create high-quality, citable question-answer pairs derived from various sources, including news articles, financial documents, and internal records, effectively transforming raw historical data into organized datasets suitable for supervised fine-tuning or reinforcement learning applications. Utilizing an agent-driven workflow, users can articulate their objectives, and the system autonomously collects relevant sources, formulates questions, evaluates outcomes based on actual events, and incorporates contextual grounding before model training. A significant advancement of this platform is its “future-as-label” approach, which leverages real-world results as training signals, enabling AI systems to learn directly from authentic outcomes at scale rather than depending on synthetic or manually curated data. This capability not only enhances the accuracy of AI models but also improves their adaptability to dynamic real-world scenarios. With Lightning Rod, organizations can harness the power of their data more effectively than ever before.

On-demand patient identity resolution is achieved by efficiently mastering and connecting data in real-time. By converting protected health information into universal, de-identified HealthVerity IDs, organizations within the life sciences sector can effectively construct and disseminate the patient journey across various partner datasets, thereby establishing a unified source of truth regarding patient identity. This approach also facilitates internal data sharing among different organizational departments, enhancing the overall understanding of the patient journey. Furthermore, it allows for adaptable external data exchanges with entities such as patient registries, health insurers, and other associated companies. HealthVerity Census serves as an initial step toward developing a data strategy focused on activation, interoperability, and the longitudinal tracking of patient information. Utilizing an advanced PaaS de-identification solution, it empowers the activation of both internal and external data touchpoints, breaking down silos that often isolate critical information within the enterprise. These comprehensive capabilities ultimately contribute to improved patient outcomes and more informed decision-making across the healthcare landscape.

ScoutITAi is an innovative platform that utilizes artificial intelligence to optimize observability and enhance the reliability of IT operations, ensuring improved performance monitoring for networks, applications, and cloud environments. Central to its functionality is the unique Reliability Path Index (RPI), which employs a scoring system comprised of 13 distinct buckets to measure IT reliability based on real-world industry insights, thereby granting dynamic visibility into the health of services. By harnessing advanced analytics alongside AI-driven insights, ScoutITAi provides users with real-time monitoring capabilities, predictive trend forecasting, and customized recommendations aimed at mitigating potential service disruptions. Among its offerings is the ScoutITAi Reliability Advisor, which leverages sophisticated analysis techniques to bolster IT service reliability, as well as a detailed dashboard that presents key application statistics and performance metrics. Users benefit from the ability to oversee network performance across various locations, enhance the efficiency of web applications, and achieve comprehensive visibility into their networks through proactive monitoring practices. This robust platform ultimately empowers organizations to maintain high service availability and respond swiftly to emerging issues, ensuring a seamless operational experience.

Organizations in the life sciences sector, regardless of their size or complexity, depend on the ICyte platform to enhance pharmaceutical market entry and therapy commercialization processes. The ICyte platform equips biotech and pharmaceutical manufacturers with exceptional services that include the aggregation of channel and patient data, management of contracts and pricing, gross-to-net forecasting, and accrual systems, as well as expert solutions for launch and pricing transparency. By utilizing ICyte, both pharmaceutical and biotech firms can significantly enhance their market access capabilities by swiftly converting patient, payer, complex transaction, and channel data into practical insights. Additionally, ICyte offers analytics-as-a-service, facilitating the deployment of standardized models and metrics as a unified service across various applications, data streams, and analytical uses. The platform integrates key performance indicators (KPIs) tailored specifically for life sciences organizations. Furthermore, it features advanced analytics tools, including forecasting, scenario modeling, and a recommendation engine powered by machine learning, which aid companies in making data-driven decisions. Ultimately, ICyte is positioned as a comprehensive solution that not only simplifies processes but also empowers organizations to navigate the complexities of the pharmaceutical landscape effectively.

Enhance your revenue in clinical research by pinpointing deficiencies in clinical care. CliniWorks’ AccelInsight™ Analytics Application facilitates Population Health Management through data-driven clinical decision-making, offering insightful reports and tools that reveal care gaps across various disease areas. With AccelInsight™, healthcare professionals can access customized, near-real-time analytics derived from extensive structured and unstructured datasets, including patient medical records and other sources, to uncover evidence-based opportunities for quality improvement, risk stratification, gap analysis, and effective care management. Additionally, AccelCare™ empowers healthcare providers to swiftly establish preferred intervention plans based on best-practice protocols, align patient cases from medical records with established medical guidelines and workflows, and trigger immediate corrective workflows alongside real-time alerts and information dissemination to quality assurance teams, management, and providers. This comprehensive approach not only enhances patient outcomes but also improves overall efficiency in healthcare delivery.

DeepSeek-VL is an innovative open-source model that integrates vision and language capabilities, catering to practical applications in real-world contexts. Our strategy revolves around three fundamental aspects: we prioritize gathering diverse and scalable data that thoroughly encompasses various real-life situations, such as web screenshots, PDFs, OCR outputs, charts, and knowledge-based information, to ensure a holistic understanding of practical environments. Additionally, we develop a taxonomy based on actual user scenarios and curate a corresponding instruction tuning dataset that enhances the model's performance. This fine-tuning process significantly elevates user satisfaction and effectiveness in real-world applications. To address efficiency while meeting the requirements of typical scenarios, DeepSeek-VL features a hybrid vision encoder that adeptly handles high-resolution images (1024 x 1024) without incurring excessive computational costs. Moreover, this design choice not only optimizes performance but also ensures accessibility for a broader range of users and applications.

Organizations, regardless of their size, depend on reliable data to guide their decision-making processes, yet traditional proxy services often suffer from sluggishness, blocking issues, or inadequacies in real-world scenarios. Aluvia addresses these obstacles by integrating sophisticated mobile proxy features—such as authentic SIM-based connections, dynamic IP rotation, sticky sessions, and precise geo-targeting—into a cohesive and user-friendly platform. Utilizing actual mobile devices connected to legitimate carrier networks, Aluvia facilitates accurate data collection and enhances coverage for tasks like competitive analysis, ad verification, SEO investigations, and fraud detection. The platform's automated features minimize the necessity for manual input, allowing your team to concentrate on strategic initiatives rather than dealing with proxy-related complications or IP restrictions. By delivering accurate, real-world data and streamlining your proxy management within a single solution, Aluvia significantly enhances performance while uncovering fresh avenues for expansion and achievement. Ultimately, this results in a more efficient workflow, enabling teams to achieve their objectives with greater ease.